Safinamide in Parkinson's Disease: A retrospective study

被引：0
|
作者：
Carmona-Abellan, M.
Erburu, M.
Cabrera, A.
Garcia-Monco, C.
Berganzo, K.
Huete, B.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1378
引用
收藏
页码：S603 / S604
页数：2
相关论文
共 50 条
  • [1] Safinamide as an adjunct therapy in older patients with Parkinson’s disease: a retrospective study
    Maria Rita Lo Monaco
    Martina Petracca
    Davide Liborio Vetrano
    Enrico Di Stasio
    Domenico Fusco
    Diego Ricciardi
    Alice Laudisio
    Giuseppe Zuccalà
    Graziano Onder
    Anna Rita Bentivoglio
    Aging Clinical and Experimental Research, 2020, 32 : 1369 - 1373
  • [2] Safinamide as an adjunct therapy in older patients with Parkinson's disease: a retrospective study
    Lo Monaco, Maria Rita
    Petracca, Martina
    Vetrano, Davide Liborio
    Di Stasio, Enrico
    Fusco, Domenico
    Ricciardi, Diego
    Laudisio, Alice
    Zuccala, Giuseppe
    Onder, Graziano
    Bentivoglio, Anna Rita
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 32 (07) : 1369 - 1373
  • [3] The tolerability, safety and efficacy of safinamide in elderly Parkinson's disease patients: a retrospective study
    Rinaldi, Domiziana
    Bianchini, Edoardo
    Sforza, Michela
    Alborghetti, Marika
    Galli, Silvia
    Salvetti, Marco
    Giovannelli, Morena
    Pontieri, Francesco E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (06) : 1689 - 1692
  • [4] Safinamide in Parkinson's disease
    Marti-Andres, G.
    Jimenez-Bolanos, R.
    Arbelo-Gonzalez, J.
    Pagonabarraga-Mora, J.
    Duran-Herrera, C.
    Carmona-Abellan, M.
    Luquin-Puido, R.
    MOVEMENT DISORDERS, 2018, 33 : S12 - S12
  • [5] The tolerability, safety and efficacy of safinamide in elderly Parkinson’s disease patients: a retrospective study
    Domiziana Rinaldi
    Edoardo Bianchini
    Michela Sforza
    Marika Alborghetti
    Silvia Galli
    Marco Salvetti
    Morena Giovannelli
    Francesco E. Pontieri
    Aging Clinical and Experimental Research, 2021, 33 : 1689 - 1692
  • [6] Dyskinesia and adherence to safinamide and opicapone in fluctuating patients with Parkinson's disease: observational retrospective study
    Lorenzo-Barreto, P.
    Parees, I.
    Perez-Torre, P.
    Fanjul, S.
    Lopez-Sendon, J. L.
    Perez-Trapote, F.
    Saez-Marin, A.
    Stiauren-Fernandez, E.
    Patino-Paton, A.
    Martinez-Castrillo, J. C.
    Alonso-Canovas, A.
    MOVEMENT DISORDERS, 2023, 38 : S614 - S615
  • [7] SAFINAMIDE FOR SYMPTOMS OF PARKINSON'S DISEASE
    Mueller, T.
    DRUGS OF TODAY, 2015, 51 (11) : 653 - 659
  • [8] Switch from rasagiline to safinamide in fluctuating Parkinson's disease patients: a retrospective, pilot study
    Bianchini, Edoardo
    Sforza, Michela
    Rinaldi, Domiziana
    Alborghetti, Marika
    De Carolis, Lanfranco
    Della Gatta, Francesco
    Pontieri, Francesco E.
    NEUROLOGICAL RESEARCH, 2021, 43 (11) : 950 - 954
  • [9] Safinamide for the treatment of Parkinson's disease
    Kandadai, Rukmini Mridula
    Jabeen, Shaik Afshan
    Kanikannan, Meena A.
    Borgohain, Rupam
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 747 - 759
  • [10] Safinamide: A Review in Parkinson's Disease
    Blair, Hannah A.
    Dhillon, Sohita
    CNS DRUGS, 2017, 31 (02) : 169 - 176
12345